[{"uuid": "1eb5e159-3fba-4b1b-82ab-7bac27d6c62d", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "76", "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "55637889-83e1-4e5e-82e2-2d9f0d534a8c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "85", "days_to_last_known_alive": null, "days_to_last_followup": "-64", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "cac2e97f-89a7-4158-a807-06614626021a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "330", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4eedd087-bd65-4c42-8467-571d0c6883e9", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "191", "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f36fb4a6-689b-4c7d-8b40-bb6ca296b95a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": null, "days_to_last_followup": "173", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": null, "start": "529", "end": "589", "duration": 60, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8f0d8abe-682e-4db6-b9d7-a20aa2a1910c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "63", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6fbd2d17-6fb4-405d-a50d-694f16afa5da", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "90", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "33064d07-dba7-4db1-ad01-5028ddf73e2f", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": "376", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "75", "end": "110", "duration": 35, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "75", "end": "110", "duration": 35, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "24", "end": "24", "duration": 0, "dosis": "3000", "dosis_unit": null}]}, {"uuid": "88e0313a-038a-499f-a1cb-25ed1b0d53ef", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "232", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "40fbccb5-368d-43c0-b817-ea017ec94da0", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "1459", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c54b7324-2233-4f02-b76c-b074fb7262f2", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "859", "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "97", "end": "169", "duration": 72, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "97", "end": "169", "duration": 72, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c187fe3e-62a2-4a25-a123-b77a998788ff", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "81", "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 1, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "94fcd416-113d-48b7-9397-49959dc2e215", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "270", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f5b5a108-a273-40b7-97d9-886326f0796b", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": "1048", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "fe0e99bd-0102-42ac-b35a-0d3585482181", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "86", "days_to_last_known_alive": null, "days_to_last_followup": "138", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "769dfbcd-030b-488e-8c1e-6b10d448e666", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "26", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": null, "start": "210", "end": "210", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1a2c055d-013b-4935-9f36-40cff999dc00", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "209", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3ceb2fc4-8171-46e0-9354-c039d5c3b089", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "214", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "methotrexate", "start": "143", "end": "145", "duration": 2, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Doxorubicin", "start": "143", "end": "145", "duration": 2, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "143", "end": "145", "duration": 2, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Vinblastine", "start": "143", "end": "145", "duration": 2, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d9dede9a-c157-4546-b43a-5ca2f6389073", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": "194", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "carboplatinum", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "gemcitabine", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "833baeaa-e9f9-4cf9-81c5-471090457680", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "223", "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 1, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e5d26648-a81b-4bb0-a081-e354bde9894a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": "19", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "174", "end": "235", "duration": 61, "dosis": "60", "dosis_unit": "Gy"}]}, {"uuid": "71e9515b-4f09-4873-b16a-1be6fe5fe5b4", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "454", "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4daebe9e-7e41-4efc-bcf3-04c54309a7f3", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": null, "days_to_last_followup": "806", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Paclitaxel", "start": "38", "end": "38", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Ancillary", "name": "MESNA", "start": "38", "end": "38", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "38", "end": "38", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Ifosfamide", "start": "38", "end": "38", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3165c538-b313-4546-967c-fe6822ad2f3a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": "232", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Carboplatin", "start": "197", "end": "246", "duration": 49, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "197", "end": "261", "duration": 64, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6c9531ff-ddf3-4e0f-8dff-c9d4a4795342", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "321", "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "56", "end": "105", "duration": 49, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "56", "end": "105", "duration": 49, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "253", "end": "270", "duration": 17, "dosis": null, "dosis_unit": null}]}, {"uuid": "075bdca2-459b-4694-878b-028ced6684c3", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "294", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b81fbe5f-307c-4f1d-ad1d-06408d0c29a7", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "144", "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c7ef66f4-5470-4e01-80f5-e6fb8923667c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "590", "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "bf815fcc-8bdb-46a9-8f58-568ec0133e9d", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": "98", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Carboplatin", "start": "105", "end": "344", "duration": 239, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "105", "end": "344", "duration": 239, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "556", "end": "569", "duration": 13, "dosis": "3000", "dosis_unit": "cGy"}]}, {"uuid": "c278e567-dc10-4e56-a2a0-87644e88fa12", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "3056", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 1, "qty_drugs": 1, "drug_details": [{"type": null, "name": null, "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b8e2df02-50f1-4ed5-88aa-4fa0e0adc3ae", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "63", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "aa427de1-fbb4-4d06-87e3-105c5d32ba8b", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "49", "days_to_last_known_alive": null, "days_to_last_followup": "3364", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "74", "end": "151", "duration": 77, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "74", "end": "151", "duration": 77, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7c0c999d-87b4-4168-8862-045f8ab70db7", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": null, "days_to_last_followup": "180", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Carboplatin", "start": "96", "end": "180", "duration": 84, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Etopside", "start": "96", "end": "180", "duration": 84, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4b67df41-db47-445b-8e9e-1348436177a4", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "1604", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b9cd0a82-950f-4311-845f-09ec29011d79", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "77", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "12beac82-e178-41a9-94d5-4d224fcc6b9c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": "243", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a9aba738-7a2f-468d-bc21-3cee3c29a73e", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "819", "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Etoposide", "start": "84", "end": "147", "duration": 63, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Taxol", "start": "84", "end": "147", "duration": 63, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "376", "end": "397", "duration": 21, "dosis": "30", "dosis_unit": "Gy"}]}, {"uuid": "440d033e-45cc-4a5e-80e9-7fbc6029c929", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "1323", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d2042888-91d8-4c04-901b-53b3ab396e82", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "530", "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "117cc78b-ad81-46c3-ac15-8caf8557278c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "3", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "87", "end": "131", "duration": 44, "dosis": "45", "dosis_unit": "Gy"}]}, {"uuid": "ae118e3f-b1da-4f82-8b0a-3896da0bffaf", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a16f0cf0-cb77-45ab-8b05-d193c685bb11", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": null, "days_to_last_followup": "250", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "238", "end": "245", "duration": 7, "dosis": "20", "dosis_unit": "Gy"}]}, {"uuid": "21e0161e-9940-4430-ac49-30aff0e2661f", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": null, "days_to_last_followup": "205", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3bf9c3ba-7b17-4055-9081-32d3f6cf6597", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "795", "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemzar", "start": "198", "end": "323", "duration": 125, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "198", "end": "323", "duration": 125, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ce93127c-d0ad-4268-a6e0-04595f4daeda", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "272", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "853e8b0b-09b8-41d2-9fb0-f6320bb25bde", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": null, "days_to_last_followup": "399", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ab97587a-9b78-480b-ba7b-38fb786af927", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": "1264", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "67843de4-bb12-4716-8a20-cb57d502d7b9", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "941", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": null, "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 2, "drug_details": [{"type": "Immunotherapy", "name": "BCG", "start": "0", "end": "0", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Immunotherapy", "name": "BCG", "start": "0", "end": "0", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d6e1491b-b0de-4068-a277-485f1554f992", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": null, "days_to_last_followup": "3", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "29", "end": "53", "duration": 24, "dosis": "36", "dosis_unit": "Gy"}]}, {"uuid": "47715e16-e4d5-4ec1-9fd2-d5ac71671d52", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "1029", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "31878073-f17f-4b22-94c0-a6710d44d7a0", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": "1952", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "13c9dd90-4807-4d8b-b7bf-77f314ed62b2", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": "34", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Gemzar", "start": "73", "end": "146", "duration": 73, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "73", "end": "106", "duration": 33, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "106", "end": "146", "duration": 40, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9a5bc905-0308-414b-b009-f3833467a3b5", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "19", "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c8f8619a-dd45-47c7-a9f1-a74f8af19cef", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "85", "days_to_last_known_alive": null, "days_to_last_followup": "84", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8c953502-a402-49d8-b696-eeca40d8639a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": null, "days_to_last_followup": "1370", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "HISPANIC OR LATINO", "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "021f9299-1bb3-48b0-a540-82933ff6ee0f", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": "390", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "819d8a4a-098a-402e-9ed7-19b2c0830fb0", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "139", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "vinblastine", "start": "62", "end": "104", "duration": 42, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "methotrexate", "start": "62", "end": "104", "duration": 42, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Adriamycin", "start": "62", "end": "104", "duration": 42, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "cisplatin", "start": "62", "end": "104", "duration": 42, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2a754ec4-0801-4f99-8bd5-0747c4d80df4", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "65", "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 1, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e7492ad4-d01a-40aa-8ba4-24ff4f389e55", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": "147", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f5ee2d9e-964a-438c-9c54-db5241f60258", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "55", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "789f9c7c-e333-404a-b636-91f5e819d753", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": null, "days_to_last_followup": "15", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e1b6a34f-7984-4015-ae3f-85f16154120e", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "1806", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine and Cisplatin", "start": "202", "end": "265", "duration": 63, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "dcd20a2f-e62a-4c48-b5f4-63238b00cee0", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "315", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "cisplatin", "start": "35", "end": "83", "duration": 48, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemzar", "start": "35", "end": "83", "duration": 48, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "805a551f-fb9c-48cd-bb28-4931f37290f9", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "193", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "bf3c6b8e-a85c-489b-aad4-df73f683706c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": "827", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6706ea04-fe7b-4ff3-8167-e0079676232a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "195", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "56", "end": "98", "duration": 42, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemzar", "start": "56", "end": "98", "duration": 42, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "231", "end": "244", "duration": 13, "dosis": "3000", "dosis_unit": "cGy"}]}, {"uuid": "f417c6ca-96f0-4b43-b58b-8ac3cf1846aa", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": "363", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 1, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5c1aeddf-2aeb-46bc-ae7d-3e71dfd94a38", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": "229", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0676fdc1-caae-419e-b971-106b72f1a486", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": "2177", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "34b2f6fb-2f1e-46b9-8330-4ac5dfc174cd", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "997", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "25c2d093-a5ad-4efa-9b89-861925902d14", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "37", "days_to_last_known_alive": null, "days_to_last_followup": "41", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "224c207a-c1c3-4340-90d5-330669dc591c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "168", "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e0769819-69e5-4b90-9fd2-3d45954f5b0b", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "359", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4663d018-861f-4100-8f9f-e1f76a2fe989", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": null, "days_to_last_followup": "359", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": null, "name": "gemcitabine", "start": "120", "end": "181", "duration": 61, "dosis": null, "dosis_unit": null}, {"type": null, "name": "cisplatin", "start": "120", "end": "181", "duration": 61, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3471e3bf-4eba-4bcb-b38e-d0bed9b3c4d9", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "593", "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "919c860f-29e2-4ff3-ac3c-bb52ddd815ab", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": "240", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9cbd4f75-d3d6-4138-b035-10906604e22a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "2027", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "687", "end": "757", "duration": 70, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "687", "end": "757", "duration": 70, "dosis": null, "dosis_unit": null}], "qty_radiation": 2, "radiation_details": [{"type": "External", "start": "880", "end": "911", "duration": 31, "dosis": "45", "dosis_unit": "Gy"}, {"type": "Internal", "start": "938", "end": null, "duration": "", "dosis": null, "dosis_unit": null}]}, {"uuid": "81deabb0-f93b-4694-9f9d-7ae8c676bc5c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "602", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "gemcitabine", "start": "146", "end": "244", "duration": 98, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "cisplatin", "start": "146", "end": "244", "duration": 98, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "88b5fda5-076b-442e-9497-eb7207612991", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "544", "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f29ea9b7-78f7-4b19-8309-4fe7efee233a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "268", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d4c1be32-da40-4813-875b-237924f269e4", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "122", "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "66f4e122-9a0e-4838-87d8-8baa738016ed", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "1423", "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "cisplatin", "start": "78", "end": "151", "duration": 73, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "gemcitabine", "start": "78", "end": "151", "duration": 73, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "39fdf655-2b52-4662-b518-b32544577700", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "575", "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "35cb95c6-9f94-4825-87b0-fd417909b4c1", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "173", "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d36131cc-fd6b-4060-8ac1-36470723a6d1", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": null, "days_to_last_followup": "137", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b42c6e6f-027f-40a4-9f1c-d204e5b96e78", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": "238", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "13175b45-5579-4d67-a667-d7c2e30234d1", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "55", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "963f8762-99df-4b80-a142-39e25cb1c05c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "253", "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "bf247677-b571-46af-9cca-a2eeaadf4e5c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": null, "days_to_last_followup": "15", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "403f29bc-7360-49f8-a2b4-301afc092bd6", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": null, "days_to_last_followup": "421", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a1675fc6-6a76-4d2f-bd1b-f705c352c343", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "1077", "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "08fbf5f3-c1b1-48ba-8905-3e040ecd1ee9", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "112", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1da5d3ac-5495-4ace-97e2-c71cb359814b", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": null, "days_to_last_followup": "42", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "312ff4da-0285-4722-b36a-49559ed61efc", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": null, "days_to_last_followup": "1301", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": null, "name": "Gemcitabine", "start": "735", "end": "820", "duration": 85, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "735", "end": "820", "duration": 85, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "48e2000c-f095-4ab7-80b4-1530526f86bd", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "128", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "483354f7-0a12-42af-9c4b-31245a0f21d7", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "237", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c6364ab0-1b79-4ac6-828e-27291e821e94", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "59", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "fe3fb90c-d9a9-42ed-ab30-c26d72d28082", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "43", "days_to_last_known_alive": null, "days_to_last_followup": "242", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7a607a66-203d-4451-a8f0-7e0265fb2b43", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": "3432", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "74cfcbf1-968c-4a96-8ea6-2116abdceffa", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": null, "days_to_last_followup": "3", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "32", "end": "92", "duration": 60, "dosis": "45", "dosis_unit": "Gy"}]}, {"uuid": "96d8fca4-76df-4315-bf10-c514ec3e2238", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "225", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4bedbdcd-069b-439f-8bef-67954d43b027", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "77", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 3, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0e9884ab-6566-4b57-9a35-8c4132cd6113", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": "1538", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "250c3c6e-25e3-445d-abd8-47f97f3344df", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": null, "days_to_last_followup": "275", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "HISPANIC OR LATINO", "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8a6cbc88-6d00-42bd-a7ec-5375eaae0851", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": "460", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1f18b1ad-0249-4b84-af2e-4598dfe71d15", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": "187", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0a8cd10e-e7f2-4afd-ade6-a73778798f16", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": "462", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "70", "end": "70", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "70", "end": "70", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "09658fbb-8010-4465-bf0e-15f6ca16bac2", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": null, "days_to_last_followup": "351", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "aac27856-9923-4df7-be82-5e4480e428d2", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": "3767", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1fc7e9eb-d27d-4da7-91ad-75dd24170f20", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": "1600", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "400d570e-7f40-4377-8f3b-1bc171ddf52a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": null, "days_to_last_followup": "253", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "gemcitabine", "start": "115", "end": "157", "duration": 42, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "cisplatin", "start": "115", "end": "157", "duration": 42, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "72c150cc-b38b-4dea-900d-af06f3b72189", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": "1434", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "166", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "166", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f9d95be8-6a90-409e-8219-a1a3f9a69d1a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "45", "days_to_last_known_alive": null, "days_to_last_followup": "982", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Paclitaxel", "start": "248", "end": "348", "duration": 100, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "248", "end": "348", "duration": 100, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "248", "end": "348", "duration": 100, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6977eda4-2df9-4a01-930c-bab258a53690", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": "372", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "165fa036-3caa-4531-822f-33cdcf8c6061", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": "284", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a500bf84-74e0-46b1-bd9a-23cdb789dc55", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": null, "days_to_last_followup": "418", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Avastin", "start": "24", "end": "75", "duration": 51, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Methotrexate", "start": "24", "end": "75", "duration": 51, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Doxorubicin", "start": "24", "end": "75", "duration": 51, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Vinblastine", "start": "24", "end": "75", "duration": 51, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "24", "end": "75", "duration": 51, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1a88cd57-f71e-4672-8dee-5ecef308ca75", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": null, "days_to_last_followup": "1072", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6cfd285b-f3b4-40ed-a531-fdb30f039d37", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": null, "days_to_last_followup": "2790", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "119", "end": "192", "duration": 73, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "119", "end": "192", "duration": 73, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "94d5b432-4183-4a67-9969-aadb4c9a6b9e", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": null, "days_to_last_followup": "380", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "80e42122-5e18-43ec-af28-d8f8b23d28b9", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": null, "days_to_last_followup": "21", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "50", "end": "89", "duration": 39, "dosis": "70", "dosis_unit": "Gy"}]}, {"uuid": "05fd00e7-72fa-41c4-9fbe-898c44d935c0", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "536", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8e33a9d2-408e-4513-bc16-4aeaf8afa9c5", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": "50", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b876b012-60ab-4f48-b084-3c0e800f24d8", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "28", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "76f3ded8-e22e-426a-a716-1be8d0a99632", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": "2293", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "127", "end": "211", "duration": 84, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "127", "end": "211", "duration": 84, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9615ebf3-b214-4226-8450-b5d4fcd4ce7d", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "719", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "136", "end": "348", "duration": 212, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Platinum", "start": "136", "end": "348", "duration": 212, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "550d33e5-90fd-42ad-b891-307aa8e1ab91", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": "197", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "eb02ffe7-9466-4f46-93bf-d7574339f4a2", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "83", "days_to_last_known_alive": null, "days_to_last_followup": "35", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a984b812-fcf0-44b7-8e05-7b2ea5d1a86b", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": "469", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "121", "end": "190", "duration": 69, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "121", "end": "190", "duration": 69, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Taxol", "start": "121", "end": "190", "duration": 69, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ac311293-ce5c-46c2-aab5-db28a4e49b35", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "154", "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "52d4fe6e-d846-4ce6-8fe6-ca1753e9e8f8", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": "88", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ce98afe2-7884-47f8-93da-f46ebdd0d47c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "2423", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6cad5c6a-c003-4797-ba24-e31135de9f0c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": "592", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Methotrexate", "start": "5", "end": "54", "duration": 49, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "vinblastine", "start": "5", "end": "54", "duration": 49, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "doxorubicin", "start": "5", "end": "54", "duration": 49, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "cisplatin", "start": "5", "end": "54", "duration": 49, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0bc986d1-fb29-42df-a97f-7b630e379ffa", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "324", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e1eda34c-b4d0-475a-9fbe-57015cee3161", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": "13", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "64a4cca0-60d2-4cc9-893f-9f47cd388285", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": "64", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d2207c22-088c-4e2e-b7f6-d3e5fa30247e", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "83", "days_to_last_known_alive": null, "days_to_last_followup": "2352", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "910be0e7-4acc-458e-b880-4fe401e9da63", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "1350", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3a15bc2a-2e70-4009-8fae-62ce37a3d0e2", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "49", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9ef03945-8eec-414d-9e59-560ab3cbd847", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": "218", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 1, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "EXTERNAL BEAM", "start": "252", "end": "258", "duration": 6, "dosis": "2700", "dosis_unit": "cGy"}]}, {"uuid": "150c2168-7c7d-4b40-aaa5-882a5f02dbeb", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": null, "days_to_last_followup": "105", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "29", "end": "166", "duration": 137, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "29", "end": "166", "duration": 137, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e8b2da5a-b682-4cf0-b095-f8a58ad59c98", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "250", "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "160b0c9a-33d8-4c07-bbe8-30c4d21a6313", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "166", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "89cda45d-1eee-4c3a-beca-3e4c0854be65", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "1775", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Tarceva", "start": "15", "end": "35", "duration": 20, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "methotrexate", "start": "135", "end": "178", "duration": 43, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "doxorubicin", "start": "135", "end": "178", "duration": 43, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "vinblastine", "start": "135", "end": "178", "duration": 43, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "cisplatin", "start": "135", "end": "178", "duration": 43, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c29a842e-beb6-43cb-ab13-63fcd270db89", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": "1538", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "35522e0b-eb04-46b6-99df-ed86420a79c0", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "129", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ee7a04d0-281b-4fd3-a7a8-d11bd664612c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "1561", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "db45383c-c206-450f-98a3-96f0e82f22d4", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": "202", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 1, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "69b0ed23-b92b-4d32-8e5b-b8b845026ce3", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "393", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 1, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "251524a7-81b2-4534-a8a5-dbc201d9fe67", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "106", "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e1dde957-5249-4949-9fdd-079cccf917ff", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "1348", "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": "Immunotherapy", "name": "BCG", "start": "0", "end": "0", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "fb31e072-dc09-4bf2-9594-6e746b67d85c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": null, "days_to_last_followup": "336", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4a9d85a3-9cf2-4604-bc49-7f0d7264c44d", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "20", "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 2, "radiation_details": [{"type": "External", "start": "5", "end": "10", "duration": 5, "dosis": "2000", "dosis_unit": "cGy"}, {"type": "External", "start": "5", "end": "10", "duration": 5, "dosis": "2000", "dosis_unit": "cGy"}]}, {"uuid": "ab53ddb6-75df-483e-a5f2-fd54884f3f13", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "370", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}]}, {"uuid": "7989c1d9-8912-4b7d-8751-b0bea33373dc", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": null, "days_to_last_followup": "1830", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d7582871-312d-4d2c-8461-1db72c5c80ff", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "1248", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7ad1200d-7759-4f48-b8de-e0cf08f0eab7", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": "42", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "16c44b17-a0df-4490-a711-3f01cacf58c5", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": "208", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c3acbc04-5d14-4660-a7e2-5e5df88cf8ab", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": null, "days_to_last_followup": "457", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 2, "drug_details": [{"type": null, "name": "Gemcitabine", "start": "27", "end": "99", "duration": 72, "dosis": null, "dosis_unit": null}, {"type": null, "name": "Cisplatin", "start": "27", "end": "99", "duration": 72, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f964b1d4-ac6b-44b9-a9ba-b6075c725861", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": "3989", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "132", "end": "235", "duration": 103, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "132", "end": "235", "duration": 103, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e96ccda5-79a1-447e-9ac7-c08817a52e98", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": "1511", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "1421", "end": "1491", "duration": 70, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "1421", "end": "1491", "duration": 70, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "62e21dae-177e-481c-96ee-52f34e825db7", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "170", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "26b623c9-913e-4beb-9080-52fd46d00767", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": "655", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": null, "end": null, "duration": "", "dosis": "4000", "dosis_unit": "cGy"}]}, {"uuid": "230c1d28-6d70-4b29-a101-a946c6f8314c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "205", "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 1, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "OTHER", "start": "140", "end": "142", "duration": 2, "dosis": "2400", "dosis_unit": "cGy"}]}, {"uuid": "71b53185-0801-451b-89af-4ae3dbade9b1", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": null, "days_to_last_followup": "2", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Carboplatin", "start": "127", "end": "149", "duration": 22, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "5FU", "start": "127", "end": "149", "duration": 22, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "127", "end": "139", "duration": 12, "dosis": "30", "dosis_unit": "Gy"}]}, {"uuid": "540b2999-df52-4f81-8751-6a2d77993e03", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "13", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4f87841c-f811-4250-8d2f-268dcc008711", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b4dc53f3-ba81-4959-b56c-3d878452a7a6", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "87", "days_to_last_known_alive": null, "days_to_last_followup": "35", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "551643fd-9a53-4051-bdbe-d21d02ca94b3", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "83", "days_to_last_known_alive": null, "days_to_last_followup": "219", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 3, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "86aeb3d9-9ce1-4724-9c0b-84352fcfe2f0", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "362", "age_at_initial_pathologic_diagnosis": "85", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "541ecc9e-461b-4e07-ae48-afc017e0d538", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "1971", "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Halichondrin B", "start": "625", "end": "996", "duration": 371, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Docetaxel", "start": "1633", "end": "1680", "duration": 47, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Ifosfamide", "start": "1759", "end": "1782", "duration": 23, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Doxorubicin", "start": "1759", "end": "1782", "duration": 23, "dosis": null, "dosis_unit": null}, {"type": "Ancillary", "name": "Mesna", "start": "1759", "end": "1782", "duration": 23, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "1187", "end": "1240", "duration": 53, "dosis": "5400", "dosis_unit": "cGy"}]}, {"uuid": "40bed0c7-25b0-490c-8a65-f76adc7a2e7b", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "1604", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a757439e-3d7c-4c17-82e1-d2bc0ed242bb", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": null, "days_to_last_followup": "3617", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 1, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "168", "end": "242", "duration": 74, "dosis": "1000", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "178", "end": "242", "duration": 64, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3ae749da-165e-44e3-bc86-f9bfb953626c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "1064", "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1d413ae0-9eb7-4516-ba1f-4ff5a821b3cf", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": "76", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "85bd66c4-d6f7-4e3d-abb5-4ba7e3ec1ff2", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "565", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "162", "end": "200", "duration": 38, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "162", "end": "200", "duration": 38, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Ifosfamide", "start": "351", "end": "374", "duration": 23, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Paclitaxel", "start": "0", "end": "9", "duration": 9, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "0", "end": "9", "duration": 9, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Docetaxel +/- Zactima", "start": "399", "end": "442", "duration": 43, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d0693fdb-b602-42aa-8410-90b46ae8d55e", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": "247", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "155", "end": "224", "duration": 69, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "155", "end": "224", "duration": 69, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ca1bebae-a129-4f44-b7d0-7796fcdea4e1", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": "187", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "88", "end": "144", "duration": 56, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "88", "end": "144", "duration": 56, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "83a1ff83-72a1-4f90-9210-90c03f608941", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "304", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Carboplatin", "start": "49", "end": "154", "duration": 105, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemzar", "start": "49", "end": "154", "duration": 105, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4f367311-c24d-49ac-9c01-d2b3c7306bee", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "544", "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": null, "start": "161", "end": "544", "duration": 383, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3d80b142-19b4-49bc-a868-168ecb605c40", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "2822", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemzar", "start": "669", "end": "853", "duration": 184, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "671", "end": "853", "duration": 182, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4f0b1350-d0fb-4ed0-8b4d-a88e5c934ce5", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": "665", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1e8f3d60-716d-496f-ba35-926ff620f13a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": null, "days_to_last_followup": "3", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a2477c47-2cf7-48c3-855f-80d8e0935e9e", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": null, "days_to_last_followup": "-27", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "058c3d96-5817-41bc-8d32-ad28ee9e61bf", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": "186", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8e33413b-9c41-4b16-8dbf-f9860f1fcebb", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7be16d37-442d-4839-9efa-476b555b0f26", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "510", "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "865b930b-53a8-4322-894e-8c42121c826a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": null, "days_to_last_followup": "243", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "949da110-b348-4405-aa4a-50a456d6c652", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": "1455", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b5cc8d75-45a2-449a-9185-dd62b0b0864a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "1761", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "68", "end": "166", "duration": 98, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "68", "end": "166", "duration": 98, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "dc7d6ac3-523e-438a-92a3-7dfc5e6e6024", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": null, "days_to_last_followup": "1917", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "63", "end": "98", "duration": 35, "dosis": null, "dosis_unit": null}]}, {"uuid": "0c7e583c-5acc-450c-8f3e-b60d20642e37", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "642", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f3aaf326-ad2f-4b0c-bf5e-d8d674d75182", "tumor_tissue_site": "Bladder", "pathologic_stage": null, "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "1174", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "56", "end": "131", "duration": 75, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "56", "end": "131", "duration": 75, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d48e78a6-17cb-4578-9215-8b4227bf330d", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "322", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "80d80888-0a83-404e-93f0-61fcd69b91b0", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": "3148", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "23b09ec3-6ce7-406a-b4c7-b58df1ccd73f", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": null, "days_to_last_followup": "407", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a2ee3383-8f06-4f4b-9ea5-7bc075614a01", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": "477", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "283", "end": "370", "duration": 87, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4f0afaba-feae-43cf-90e8-fc55a6c39c78", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": null, "days_to_last_followup": "646", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "43", "end": "113", "duration": 70, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "43", "end": "113", "duration": 70, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e9b7d1fb-5c01-4fa5-9245-e82569c06d3d", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "1718", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 17, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "53", "end": "53", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Pacitaxol", "start": "53", "end": "175", "duration": 122, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemzar", "start": "53", "end": "175", "duration": 122, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Halichondrin", "start": "614", "end": "866", "duration": 252, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Ifosfamide", "start": "898", "end": "1052", "duration": 154, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Taxol", "start": "898", "end": "1052", "duration": 154, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "898", "end": "1052", "duration": 154, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Adriamycin (doxorubicin)", "start": "1094", "end": "1136", "duration": 42, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "1094", "end": "1136", "duration": 42, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Adriamycin (doxorubicin)", "start": "1265", "end": "1318", "duration": 53, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "1265", "end": "1318", "duration": 53, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "1423", "end": "1486", "duration": 63, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Adriamycin (doxorubicin)", "start": "1465", "end": "1486", "duration": 21, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "1598", "end": "1598", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Adriamycin (doxorubicin)", "start": "1598", "end": "1598", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Temsirolimus", "start": "1703", "end": "1703", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Vinorelbine", "start": "1703", "end": "1703", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4f78ed91-944f-4506-912c-517eb9391766", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "251", "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "fda52772-e531-45fc-bbc7-45bb8cc80e83", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "134", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c55cce55-2ed5-4b0d-a7a9-9f4790932b72", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": null, "days_to_last_followup": "242", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "HISPANIC OR LATINO", "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "215", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "214", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1ca0143d-54ed-4e46-92d3-51973bde878a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": null, "days_to_last_followup": "20", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "91f6fe9a-4eff-4e12-8a83-2d9bd6b8c5e3", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": "162", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "57f3f634-d6c9-48a3-99ae-a34684adb1f6", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": "20", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "954facf0-b4de-4731-8634-04a9830bdee9", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": "567", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "44f55b11-ec37-445f-bc8c-c3313ff6147b", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": "209", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ce5efeae-5184-4e17-bec9-00fa6a07e5ed", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "90", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "021d0c7f-e484-4bf7-b3b8-b89c091a8f48", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "98", "age_at_initial_pathologic_diagnosis": "83", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e17308de-4d2d-44fa-8ff2-08c2740ee454", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "68", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1a05883d-06c4-496c-b2fd-93dd87b257d8", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": "121", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ef74efb5-f947-4403-91d7-6ae046d2e355", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": null, "days_to_last_followup": "19", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "5315ac62-225b-49bc-9293-e91eae4e8cc2", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "17", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "da716264-7609-4f31-9c17-86758ff64727", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": "239", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b8f4617a-5c64-49d3-9da4-dd2935937f20", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "125", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e5c1d966-9f12-4d52-9b31-b282982d7d2e", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "507", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "aa8a6122-5e13-4ce4-a042-30abb52f1281", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "45", "days_to_last_known_alive": null, "days_to_last_followup": "68", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ee571f04-2783-43d8-a60e-97ef6b1a3576", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "87", "days_to_last_known_alive": null, "days_to_last_followup": "67", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "82489a14-8825-4eee-a558-a160869fd989", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "413", "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "68640795-c007-4973-9e67-f1cf023598cc", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "273", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Carboplatin", "start": "123", "end": "212", "duration": 89, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Etoposide", "start": "123", "end": "212", "duration": 89, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Doxorubicin", "start": "243", "end": "243", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4f012eae-3a1e-49d7-9f5e-88806cb7bcfa", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": "110", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7d8b496b-c4e4-4375-ac7f-9dacc3dd2519", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "111", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Carboplatin", "start": "458", "end": "611", "duration": 153, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Taxol", "start": "458", "end": "611", "duration": 153, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "555", "end": "555", "duration": 0, "dosis": null, "dosis_unit": null}]}, {"uuid": "fe516932-fdb1-40e1-ad2a-638c7a6b7c9b", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "86", "days_to_last_known_alive": null, "days_to_last_followup": "224", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "24d5b7df-c853-4788-a971-50329391ff60", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "493", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "bcc6ca6b-cec6-47c4-8df7-e09cd3a112b2", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": null, "days_to_last_followup": "366", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "54", "end": "114", "duration": 60, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemzar", "start": "54", "end": "114", "duration": 60, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c882301d-abad-4c1b-afca-d8e9460f699f", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "274", "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "149", "end": "155", "duration": 6, "dosis": "20", "dosis_unit": "Gy"}]}, {"uuid": "2aeea5aa-529b-4cae-aa38-8dbb3a1d0f5a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": "1130", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "777", "end": "854", "duration": 77, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "777", "end": "854", "duration": 77, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "003bc96d-e7e8-49e2-83db-a5dcb6f6cd47", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "612", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d801fccc-eea6-4f2c-a066-4df7ac0d0624", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "16", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "fd1838c0-8bea-4994-adb5-f7e8a2bfcd6e", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": "204", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "acff143d-dcf8-42db-bfff-f718b9d28cc1", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": null, "days_to_last_followup": "93", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f46bfb20-8ddb-4675-a629-667f6721fd7f", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "1670", "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "82", "end": "143", "duration": 61, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "platinum", "start": "82", "end": "143", "duration": 61, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "173", "end": "204", "duration": 31, "dosis": null, "dosis_unit": null}]}, {"uuid": "e17cb6d1-69dc-4b63-a008-d5851e0c0f2f", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": null, "days_to_last_followup": "352", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "521", "end": "578", "duration": 57, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "521", "end": "578", "duration": 57, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b057fe6a-6cfb-4e29-a519-cfef91cb18b9", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": null, "days_to_last_followup": "67", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e2dfcb8d-b7a2-4623-b381-603268bd6eff", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "147", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "eb9689be-5a1f-4e17-a130-982f8260e969", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "262", "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "37501e2d-f376-4786-911d-e95be3382d3d", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "83", "days_to_last_known_alive": null, "days_to_last_followup": "921", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "38bc69b8-7b97-4a14-9208-5ec5dbacc3ba", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": "273", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 1, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "133", "end": "246", "duration": 113, "dosis": "1000", "dosis_unit": "mg/m2"}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "133", "end": "246", "duration": 113, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "352dfb05-4578-4b89-895a-ae7041fe707a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": "178", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "289", "end": "435", "duration": 146, "dosis": "800", "dosis_unit": "mg/m2"}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "87169308-5ea0-4f54-b818-c09f8bb17b77", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "90", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c49a9761-28c8-42b9-a181-34e8205e85be", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "2020", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8c6637ad-048e-4c3d-82ef-9b143efc3d49", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "271", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 1, "qty_drugs": 1, "drug_details": [{"type": null, "name": null, "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4b8bdf1c-6b4c-474d-b949-0d0cefa781e2", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": "1108", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Methotrexate", "start": null, "end": "139", "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Vinblastine", "start": null, "end": "139", "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Adriamycin", "start": null, "end": "139", "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": null, "end": "139", "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0a8ff84d-79c5-445a-95a9-24a300b09af5", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "14", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2d653c78-14d7-42ac-ac2a-23edec378e6b", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": "320", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "027b53df-0c1f-4e4f-8e11-7368fc9c005a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "206", "age_at_initial_pathologic_diagnosis": "87", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6766b8dc-fe24-4e9c-8347-fe12d844e8b9", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": "1094", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Carboplatin", "start": "189", "end": "331", "duration": 142, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "189", "end": "331", "duration": 142, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4f99193e-ff36-4089-b090-cd44b6fc11af", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "85", "days_to_last_known_alive": null, "days_to_last_followup": "525", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b5c06cf4-6549-4585-97a7-3ad7e592126f", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "823", "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b8b46c6d-0158-4890-bfca-7ce6a538c1ca", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "1178", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "69", "end": "148", "duration": 79, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "69", "end": "148", "duration": 79, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d774a5c4-b9fb-4734-ba85-49e8b8463efb", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "89", "days_to_last_known_alive": null, "days_to_last_followup": "361", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a9bbe97a-773c-45b0-a69f-64d6563428ef", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "272", "age_at_initial_pathologic_diagnosis": "49", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 4, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "84", "end": "91", "duration": 7, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "84", "end": "205", "duration": 121, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Methotrexate", "start": "113", "end": "205", "duration": 92, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Vinblastine", "start": "113", "end": "205", "duration": 92, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Doxorubicin", "start": "113", "end": "189", "duration": 76, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8695dfe4-d0e9-4a7a-bb08-b79a80fc3502", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": null, "days_to_last_followup": "955", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 3, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "97f42860-f27e-458e-a61d-5c2da50c930f", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": "4684", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "125", "end": "204", "duration": 79, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "125", "end": "204", "duration": 79, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "fc056214-5e5a-4b74-baaf-f4164e9e99a1", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "579", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3a5e0005-8ffb-417c-9b13-27b1b2eba7a7", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "276", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "220", "end": "248", "duration": 28, "dosis": "3500", "dosis_unit": "cGy"}]}, {"uuid": "f58e4c78-a295-40cf-8d3d-65fa5d2c0228", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": null, "days_to_last_followup": "158", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c3565ccc-109f-4c26-9f37-40e8f773de77", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "612", "age_at_initial_pathologic_diagnosis": "51", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 7, "drug_details": [{"type": "Chemotherapy", "name": "Ifosfamide", "start": "29", "end": "68", "duration": 39, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Doxorubicin", "start": "29", "end": "68", "duration": 39, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "29", "end": "68", "duration": 39, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Methotrexate", "start": "81", "end": "100", "duration": 19, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Doxorubicin", "start": "81", "end": "100", "duration": 19, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Vinblastine", "start": "81", "end": "100", "duration": 19, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "81", "end": "100", "duration": 19, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "09fa6864-ab55-4dc2-86ba-5635ccd7def4", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": "433", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0f58586e-5b8e-4d18-b402-f61bcbc86019", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "864", "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "199989a2-01a1-43bf-97db-f02b704bf617", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage I", "histological_type": null, "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "389", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 5, "qty_drugs": 1, "drug_details": [{"type": "Immunotherapy", "name": "BCG", "start": "680", "end": "722", "duration": 42, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "dc9112bc-25f5-487b-9038-2cc33be3ad1b", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": "678", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "bb406d5c-e028-4a2d-88c1-4c7a50614db2", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "615", "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6fa92eee-8fb3-4b19-849b-4133912f88b4", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "344", "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "651c090d-e5c3-40d2-91a6-2091ed7b5f98", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "62", "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6025f160-38d6-487e-b39b-90684bd5057e", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "87", "days_to_last_known_alive": null, "days_to_last_followup": "62", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "76d231b6-bdc8-4c96-9ce9-4acfe7cbef35", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "455", "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "44c55812-88c4-4eb9-a975-c59f46492c1d", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "56", "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "defc64a6-ed42-4793-a3d4-fe8f16d5bbcb", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "34", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "102", "end": "138", "duration": 36, "dosis": "50", "dosis_unit": "Gy"}]}, {"uuid": "6bb58e27-8bd7-4ad5-9e11-6cc96eccc02b", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "467", "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "gemcitabine", "start": "351", "end": "421", "duration": 70, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "cisplatin", "start": "351", "end": "421", "duration": 70, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "435", "end": "448", "duration": 13, "dosis": "300", "dosis_unit": "cGy"}]}, {"uuid": "5bab24e0-f17f-413f-8067-6bca5f71cf38", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "19cab7e8-b4ee-487d-810a-d0da6627dafd", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": "378", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1147b8cd-8bbb-4c2e-9041-0e33f9c29289", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "195", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Carboplatin", "start": "291", "end": "321", "duration": 30, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemzar", "start": "291", "end": "321", "duration": 30, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "321", "end": "321", "duration": 0, "dosis": null, "dosis_unit": null}]}, {"uuid": "dcca377e-c1e7-45b6-9a2c-66833e18bb92", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": "231", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f8cf9a68-67bb-4a7a-9cd5-748f611f9250", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": null, "days_to_last_followup": "224", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "73e14976-2182-4377-8d11-0ef8ffb084fc", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "203c6051-63d1-4f4e-8751-64747b6ec1a0", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "328", "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "042a6021-7a59-4ea5-949d-6076a8a3b869", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": null, "days_to_last_followup": "252", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "127", "end": "177", "duration": 50, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "127", "end": "177", "duration": 50, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Taxol", "start": "127", "end": "177", "duration": 50, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f0d005d3-fb44-43f7-afb4-3697d9541a4a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "119", "end": "146", "duration": 27, "dosis": "50", "dosis_unit": "Gy"}]}, {"uuid": "69fa5d0d-f039-44f0-a829-c404845ac688", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": null, "days_to_last_followup": "235", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 3, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": null, "start": "111", "end": "325", "duration": 214, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "327", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "327", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": null, "name": "fosaprepitant", "start": "327", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": null, "start": "237", "end": "310", "duration": 73, "dosis": null, "dosis_unit": null}]}, {"uuid": "ba746484-5a96-4fdb-9ed7-c2a39acce08c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "974", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7d9c4692-2214-44d0-9f9e-bf6c203661e9", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": null, "days_to_last_followup": "177", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "58", "end": "156", "duration": 98, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "58", "end": "156", "duration": 98, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Docetaxel", "start": "499", "end": "549", "duration": 50, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f7a85cc8-c0c8-4547-83af-9c1885b46775", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "453", "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Gemzar", "start": "161", "end": "263", "duration": 102, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "161", "end": "263", "duration": 102, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Docetaxel", "start": "263", "end": "331", "duration": 68, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Oxaliplatin", "start": "263", "end": "331", "duration": 68, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "419", "end": "419", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "881001f7-1f40-459d-95a3-24d263e980d4", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": null, "days_to_last_followup": "214", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 1, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": null, "start": "92", "end": "153", "duration": 61, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "52eff62b-563b-4052-ab07-384200acb70f", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "263", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "263", "end": "328", "duration": 65, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "263", "end": "295", "duration": 32, "dosis": "4500", "dosis_unit": "cGy"}]}, {"uuid": "8a137f31-9876-4b29-8c45-27247b677ce5", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": "142", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9efca097-8df2-4af3-b99f-4ef8ad58bf8d", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "408", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4e196e89-6a20-4e03-a829-702ea923b6ff", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "168", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "gemcitabine", "start": "65", "end": "141", "duration": 76, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "cisplatin", "start": "66", "end": "141", "duration": 75, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c58ead36-ac41-4192-a0e5-dfeef605f10a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "46", "days_to_last_known_alive": null, "days_to_last_followup": "111", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6bfc024b-d71b-40f3-a28f-9561a88d4be7", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "1709", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2661c428-7146-44be-99f8-2bf2cde7f1fd", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "87", "days_to_last_known_alive": null, "days_to_last_followup": "105", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "345beac8-2975-4690-9fdb-7e29111c1872", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": "405", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "bbd8c337-ae60-46af-8600-5417fbbc3c10", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "599", "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ecf628b7-5e05-4a56-ae4d-da13951cdde7", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "44", "days_to_last_known_alive": null, "days_to_last_followup": "37", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4d900bda-5579-49ca-b5b5-b779442bf4ec", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "334", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "gemcitabine", "start": "302", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "cisplatin", "start": "302", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "21511857-462f-40a2-909d-b86756359b00", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage I", "histological_type": null, "days_to_death": null, "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": null, "days_to_last_followup": "9", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6c1fd2ce-e97d-4d69-aa75-72d07ba66ded", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "213", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6e285f59-2fa2-4d44-bca3-daa147054633", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": "33", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "68", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "68", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a46e9941-8cec-48f2-91f6-4895993e4c62", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "495", "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 5, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "158", "end": "281", "duration": 123, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "158", "end": "281", "duration": 123, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Ifosfamide", "start": "402", "end": "436", "duration": 34, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Paclitaxel", "start": "402", "end": "436", "duration": 34, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "402", "end": "436", "duration": 34, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "86f02d3c-a65a-4090-a6ee-a01451cb9f49", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "122", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "960c9ac4-c0c2-4bb5-b7c5-4ceca7e5591c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": "61", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "59ac4fa5-6cf7-47cd-b4ad-e1babb585eda", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": null, "days_to_last_followup": "2292", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "443df9f6-e2d7-48c2-ac10-f1047cf36528", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": null, "days_to_last_followup": "742", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "626b13c3-cac2-4442-9f5a-24db6badbda9", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "18", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "036eec0d-3cb4-4a40-9a3e-46a1e21061f0", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "60", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "gemcitabine", "start": "87", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "cisplatin", "start": "87", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "12cf12a5-076a-433d-ae81-8575c9e4be1b", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "154", "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "67b4b794-5fa4-478b-9de7-cab673617586", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "57", "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "763ecf85-b7da-402d-af32-3f8720d8d86f", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": "799", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a30add63-c41f-4a1e-b477-9f3265d13192", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "1602", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "acafeda0-8e70-4e1c-9099-b9f945f3a214", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "200", "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 1, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a2940f61-894b-4b18-bf88-eaf7048418c9", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "78", "days_to_last_known_alive": null, "days_to_last_followup": "2062", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4a6a461d-e40c-424f-a405-9b2af15fb4ab", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "710", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ae788ab7-639a-42fe-ae80-e3a0b49789f6", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": "106", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 3, "radiation_details": [{"type": "External", "start": "62", "end": "99", "duration": 37, "dosis": "5600", "dosis_unit": "cGy"}, {"type": "External", "start": "275", "end": "299", "duration": 24, "dosis": "3000", "dosis_unit": "cGy"}, {"type": "External", "start": "56", "end": "99", "duration": 43, "dosis": "5600", "dosis_unit": "cGy"}]}, {"uuid": "31dba231-0b02-40ec-99fd-c3807b04248a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "1036", "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "16cd0996-7562-4fe9-b01a-81d4207748f0", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": "-21", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "fd3a0e60-4a6a-4d21-96c7-659aa200ac16", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": null, "days_to_last_followup": "46", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e4f9343b-5e12-4a7d-92a4-d1f4ccb6bd6d", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": "308", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d0650b5f-62e6-435e-bf5c-748026ad2e4d", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "99", "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "00780bca-a22b-4685-aa91-b5462830c446", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": null, "days_to_last_followup": "14", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "022f80f5-ee7d-4bbc-bbf4-99e973b294e8", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": "209", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Carboplatin", "start": "160", "end": "307", "duration": 147, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Taxol", "start": "160", "end": "279", "duration": 119, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7d6dbb45-b8be-431b-aa33-4922362ff262", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "784", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "gemcitabine", "start": "83", "end": "145", "duration": 62, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "cisplatin", "start": "83", "end": "145", "duration": 62, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "691d9213-0d83-4f40-b607-28e14bfb1050", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "2641", "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "010d8cd3-3d49-4f35-8f14-5a0111245453", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "56", "days_to_last_known_alive": null, "days_to_last_followup": "203", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "126", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "126", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "fa31de58-eb6c-4c92-ad16-a8ca194aa2e5", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": "2625", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Cisplatin", "start": "121", "end": "142", "duration": 21, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "121", "end": "142", "duration": 21, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "689cf101-5f4b-4e09-9e30-6df183326abe", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "259", "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a61f02cb-76ea-4014-adac-f78872af20ea", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": null, "days_to_last_followup": "625", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e9d122a4-93c8-43b9-a029-07914987b822", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": null, "days_to_last_followup": "-35", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "257f53dd-5b45-4d8f-80e0-ab17793778ab", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": "319", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Carboplatin", "start": "277", "end": "319", "duration": 42, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "277", "end": "417", "duration": 140, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c6e6d6e2-efac-4289-ab5f-ba5573a24ec2", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": null, "days_to_last_followup": "168", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "296d11f5-90e9-4969-b30f-2bbfff903a57", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": "208", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "cisplatin", "start": "117", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "gemcitabine", "start": "117", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f1cce01b-dec2-4b85-910f-32ec88a65e6f", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "835", "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "de829207-137a-425c-9705-711100b2b704", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "640", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Carboplatin", "start": "199", "end": "256", "duration": 57, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "199", "end": "256", "duration": 57, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7d864af5-43e9-4518-8146-78be8f533fc6", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": null, "days_to_last_followup": "175", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "gemcitabine", "start": "111", "end": "175", "duration": 64, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "cisplatin", "start": "111", "end": "175", "duration": 64, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3f773f53-7fed-4820-807e-2eb3982ae781", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "418", "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "110afa8c-07b3-4ff6-a852-50e249620777", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "1869", "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7c608091-095e-4dbc-b75c-eaab5611a32a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "4670", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Ifosfamide", "start": "575", "end": "710", "duration": 135, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "575", "end": "710", "duration": 135, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Paclitaxel", "start": "575", "end": "710", "duration": 135, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "612", "end": "661", "duration": 49, "dosis": "5940", "dosis_unit": "cGy"}]}, {"uuid": "7b1815ee-6686-412e-8450-79efb8eee936", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "52", "days_to_last_known_alive": null, "days_to_last_followup": "1943", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2eb997cb-c94a-4988-8c6e-0897f38f6118", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "142", "age_at_initial_pathologic_diagnosis": "76", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "136e0dba-de8d-4606-abd0-8918ce1ed2f7", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "56", "age_at_initial_pathologic_diagnosis": "83", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "de2e3502-3af9-4949-968d-072b8629554d", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": "266", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "18afe7ef-871b-42ec-a9c2-2b7ccf639585", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": null, "days_to_last_followup": "89", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": null, "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "98125746-8b54-4c6f-8f96-8c8c9163585c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "41", "days_to_last_known_alive": null, "days_to_last_followup": "4", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Immunotherapy", "name": "Bacillus Calmette-Guerin (BCG)", "start": "109", "end": "317", "duration": 208, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Doxobubicin", "start": "109", "end": "324", "duration": 215, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "109", "end": "115", "duration": 6, "dosis": "30", "dosis_unit": "Gy"}]}, {"uuid": "d2b36efc-fa9c-4d11-87b9-b76bf8a580d5", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "163", "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e879882c-cdbf-4ae3-99da-66e8899e4fdd", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "2312", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4c6a3bc7-b10d-425d-9170-08a20b0d8b82", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "467", "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a8eb48e1-bfd2-4986-ac8a-025f9a764120", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": "2509", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ed91492e-82bf-43a7-a546-6b89b7a818c2", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "2828", "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 3, "drug_details": [{"type": "Chemotherapy", "name": "Carboplatin", "start": "2569", "end": "2569", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "2500", "end": "2543", "duration": 43, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "2500", "end": "2543", "duration": 43, "dosis": null, "dosis_unit": null}], "qty_radiation": 2, "radiation_details": [{"type": "External", "start": "1821", "end": "1871", "duration": 50, "dosis": "45", "dosis_unit": "Gy"}, {"type": "External", "start": "2569", "end": "2613", "duration": 44, "dosis": "60", "dosis_unit": "Gy"}]}, {"uuid": "55195bad-187e-4443-b317-2b470a1127fc", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": "323", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Immunotherapy", "name": "Ipilimumab", "start": "601", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Immunotherapy", "name": "Nivolumab", "start": "601", "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "84ab9038-f9a2-427b-ae40-94eee7d68d8e", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6675d6a4-a04d-4018-a0be-3ab347af9e62", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "739", "age_at_initial_pathologic_diagnosis": "59", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 6, "drug_details": [{"type": "Chemotherapy", "name": "carboplatin", "start": "401", "end": "436", "duration": 35, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "gemcitabine", "start": "315", "end": "436", "duration": 121, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "vinblastine", "start": "274", "end": "275", "duration": 1, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Adriamycin", "start": "274", "end": "275", "duration": 1, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "cisplatin", "start": "274", "end": "380", "duration": 106, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "methotrexate", "start": "274", "end": "275", "duration": 1, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "53928a58-76ca-47ff-95da-724bad01d636", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": null, "days_to_last_followup": "1127", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "152", "end": "232", "duration": 80, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatnin", "start": "152", "end": "232", "duration": 80, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0e3a35f7-5f89-42ba-be34-d829367d81b1", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": null, "days_to_last_followup": "319", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "13", "end": "90", "duration": 77, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "13", "end": "90", "duration": 77, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7e930dc6-d340-426a-8513-5c7b528dd6f5", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": null, "days_to_last_followup": "415", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c837385b-ec64-43cb-bbe8-9e0d3d06b3f7", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "82", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d5a47c15-a082-4fb1-88be-417cb5934299", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "81", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "682a5831-ce5a-448a-a40e-69efff0970a7", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "200", "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ea865265-35ed-4fd9-bb33-3cceb299174e", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": null, "days_to_last_followup": "95", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8c3b5520-3e8f-4993-92d4-f0367a8500d6", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "53", "days_to_last_known_alive": null, "days_to_last_followup": "734", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4234003e-ffce-4646-b176-adef4f8a9462", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": null, "days_to_last_followup": "126", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 1, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "771", "end": "895", "duration": 124, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "50135b62-5090-448a-ac76-8130958f75b7", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": null, "days_to_death": "88", "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e0a775c2-5907-4a6e-bc9c-3c2d2294608a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "118", "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ece650e3-e207-45a0-8d9f-5e7587d2d524", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "124", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "41", "end": "104", "duration": 63, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "41", "end": "104", "duration": 63, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1e677ede-5439-4798-9f65-425b05a6eef3", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "42", "days_to_last_known_alive": null, "days_to_last_followup": "2", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6591ba87-617f-4ffe-8321-fab98291d057", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "272", "age_at_initial_pathologic_diagnosis": "86", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Dead", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6361c169-df88-40dc-88b7-68b50f4be61c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "294", "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "17", "end": "87", "duration": 70, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "17", "end": "87", "duration": 70, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c45661f8-b09b-43d7-88b4-da38361d9339", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "47", "days_to_last_known_alive": null, "days_to_last_followup": "2964", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8d1f13a7-dd6f-4098-a4c1-93fa43c65be5", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "83", "days_to_last_known_alive": null, "days_to_last_followup": "197", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 2, "radiation_details": [{"type": "External", "start": "127", "end": "173", "duration": 46, "dosis": "5040", "dosis_unit": "cGy"}, {"type": "External", "start": "176", "end": "187", "duration": 11, "dosis": "3000", "dosis_unit": "cGy"}]}, {"uuid": "c8f9b79c-3f84-48f7-a90f-6825420946bf", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "211", "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "cisplatin", "start": "111", "end": "200", "duration": 89, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "gemcitabine", "start": "111", "end": "200", "duration": 89, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2d87500f-41bd-4afd-acd3-feb72413d78c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "54", "days_to_last_known_alive": null, "days_to_last_followup": "125", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "b151d03c-3583-4ad2-a919-d25d1b1a524c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "73", "days_to_last_known_alive": null, "days_to_last_followup": "81", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "bdc1bd51-93e0-4967-96f8-8d97f3850d37", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "13", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "143", "end": "196", "duration": 53, "dosis": "68", "dosis_unit": "Gy"}]}, {"uuid": "1bc85ae2-24e3-447c-a69a-654b75d87a7b", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "182", "age_at_initial_pathologic_diagnosis": "74", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "137", "end": "137", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "137", "end": "137", "duration": 0, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": "External", "start": "107", "end": "117", "duration": 10, "dosis": "30", "dosis_unit": "Gy"}]}, {"uuid": "c3cf5884-1ce0-41de-92b4-ef85720fcba0", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "50", "days_to_last_known_alive": null, "days_to_last_followup": "1518", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Methotrexate", "start": "58", "end": "170", "duration": 112, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Vinblastine", "start": "58", "end": "170", "duration": 112, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Adriamycin", "start": "58", "end": "170", "duration": 112, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "58", "end": "170", "duration": 112, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e0205888-beef-4f15-b96a-c24ba8fdcf51", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "61", "days_to_last_known_alive": null, "days_to_last_followup": "1966", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "cd6b6f74-93a6-4550-b61e-ce0f0592bf59", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": "2705", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "feea5188-2e6a-4764-b093-a410d6b91a68", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "340", "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "40e7a2f9-df64-4cc4-a69e-53e0999bea17", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "80", "days_to_last_known_alive": null, "days_to_last_followup": "197", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "d158b705-6a86-49f1-932e-52551ba4c59b", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": "2000", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ab094308-57a3-4d3c-aa76-84fc3b24736b", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "0", "age_at_initial_pathologic_diagnosis": "90", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "edde4463-b0f5-41be-81eb-cd3d3e8066d8", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "149", "age_at_initial_pathologic_diagnosis": "84", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 1, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "22fafae0-53ec-461e-a793-cf9d6b71cf4f", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "77", "days_to_last_known_alive": null, "days_to_last_followup": "2268", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2b7afde9-7b56-4deb-ad9f-56b8d39b00d5", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "69", "days_to_last_known_alive": null, "days_to_last_followup": "2555", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "1da9dd49-7230-4876-bec9-e363b2e0d350", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "486", "age_at_initial_pathologic_diagnosis": "65", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 3, "drug_details": [{"type": "Immunotherapy", "name": "BCG, Intravesicular", "start": null, "end": "-368", "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemzar", "start": "142", "end": "304", "duration": 162, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Platinol", "start": "142", "end": "304", "duration": 162, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a7809578-aad4-458d-9d76-02539054c3d3", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "6703ed3f-723d-4d74-b4a5-c822c9904736", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": "208", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "cisplatin", "start": "97", "end": "187", "duration": 90, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "gemcitabine", "start": "97", "end": "187", "duration": 90, "dosis": null, "dosis_unit": null}], "qty_radiation": 1, "radiation_details": [{"type": null, "start": "533", "end": "533", "duration": 0, "dosis": "30", "dosis_unit": "Gy"}]}, {"uuid": "7a27d876-5b76-4efa-8337-9a1201d7b7bb", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "58", "days_to_last_known_alive": null, "days_to_last_followup": "1541", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Methotrexate", "start": "55", "end": "92", "duration": 37, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Vinblastine", "start": "55", "end": "92", "duration": 37, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Adriamycin", "start": "55", "end": "92", "duration": 37, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "55", "end": "92", "duration": 37, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7ff6a958-120c-4228-9372-a12d252b1f7a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "329", "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "161", "end": "274", "duration": 113, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "161", "end": "274", "duration": 113, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7a16cd97-8da4-495e-a7a0-9a35c5d391b2", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": null, "days_to_last_followup": "147", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "912d9018-cf42-4ca0-a86f-696bf236d834", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": null, "days_to_last_followup": "1479", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "HISPANIC OR LATINO", "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "df177bda-067e-49ef-b5e7-f4459def6a15", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "63", "days_to_last_known_alive": null, "days_to_last_followup": "67", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "62f0d78c-1ba7-43e0-b996-456900501a02", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "88", "days_to_last_known_alive": null, "days_to_last_followup": "64", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f97b048b-200f-4a9c-88dc-60e8e5682925", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "364", "age_at_initial_pathologic_diagnosis": "66", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "4247ce9c-c8e7-4b95-b357-7b02c1b2c7f8", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": null, "days_to_last_followup": "796", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": null, "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "gemcitabine", "start": "37", "end": "114", "duration": 77, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "37", "end": "114", "duration": 77, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": null, "start": "719", "end": null, "duration": "", "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "docetaxel", "start": "1024", "end": "1150", "duration": 126, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e375527f-490a-4502-8905-0b521a3d0587", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "388", "age_at_initial_pathologic_diagnosis": "82", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 4, "drug_details": [{"type": "Immunotherapy", "name": "BCG", "start": "0", "end": "0", "duration": 0, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "gemcitabine", "start": "174", "end": "208", "duration": 34, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "174", "end": "208", "duration": 34, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "SAHA/Vorinostat", "start": "258", "end": "342", "duration": 84, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "8d26d9df-c17d-4c79-817e-72f0f6e13ffc", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "68", "days_to_last_known_alive": null, "days_to_last_followup": "1151", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "a4a6ddd8-b6fe-4b4d-accf-5df8ffcbe43a", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "254", "age_at_initial_pathologic_diagnosis": "71", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "7c568301-72d5-42f4-8900-52a44825a524", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": "237", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "CDDP", "start": "135", "end": "170", "duration": 35, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Gemcitabine", "start": "135", "end": "170", "duration": 35, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "2cf3f9fc-d3ed-4626-9154-8dbbb5defa3c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "70", "days_to_last_known_alive": null, "days_to_last_followup": "0", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 6, "qty_drugs": 0, "drug_details": [], "qty_radiation": 2, "radiation_details": [{"type": "External", "start": "369", "end": "407", "duration": 38, "dosis": "58", "dosis_unit": "Gy"}, {"type": "External", "start": "620", "end": "662", "duration": 42, "dosis": "50", "dosis_unit": "Gy"}]}, {"uuid": "9c75da28-ff7e-4c93-ae8a-2a6d7c3b6f75", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "62", "days_to_last_known_alive": null, "days_to_last_followup": "171", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "cdc79c25-4f81-4247-ba3f-d67ff0690f4e", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "547", "age_at_initial_pathologic_diagnosis": "85", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "c2335d67-7cfb-4549-a185-2c34c48515bd", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "1163", "age_at_initial_pathologic_diagnosis": "48", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Dead", "qty_follow_ups": 0, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0b502ac2-61c4-4c24-a276-71d8aa4ae793", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "49", "days_to_last_known_alive": null, "days_to_last_followup": "660", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "bb1a3e28-933d-4121-ae47-8128dac80eb7", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "67", "days_to_last_known_alive": null, "days_to_last_followup": "2049", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "0fd3d226-55d1-4982-b17f-ef9e2bf283be", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "194", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "BLACK OR AFRICAN AMERICAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "243", "end": "292", "duration": 49, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Carboplatin", "start": "243", "end": "292", "duration": 49, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "9ac6417e-cd3f-473f-b062-3c7d6081277c", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "60", "days_to_last_known_alive": null, "days_to_last_followup": "583", "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "135", "end": "177", "duration": 42, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "135", "end": "177", "duration": 42, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "02c8a92c-69af-4f06-a53b-23afb8ff023b", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "75", "days_to_last_known_alive": null, "days_to_last_followup": "17", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ea8c4fa1-be3d-4406-bb1a-d32148130f42", "tumor_tissue_site": "Bladder", "pathologic_stage": null, "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": null, "days_to_last_followup": "217", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 2, "drug_details": [{"type": "Chemotherapy", "name": "Gemcitabine", "start": "32", "end": "122", "duration": 90, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "46", "end": "89", "duration": 43, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "f97b25c1-4162-4df0-91b0-71c4b583e75d", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "64", "days_to_last_known_alive": null, "days_to_last_followup": "130", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 1, "drug_details": [{"type": null, "name": null, "start": null, "end": null, "duration": "", "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "e6055dce-c4a0-412b-8e94-ce29f0e96de6", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage III", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "55", "days_to_last_known_alive": null, "days_to_last_followup": "25", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Alive", "qty_follow_ups": 4, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "482a985b-887c-4cec-ab7a-db64cbfda4cc", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": "690", "age_at_initial_pathologic_diagnosis": "81", "days_to_last_known_alive": null, "days_to_last_followup": null, "days_to_last_follow_up": "", "gender": "FEMALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "ASIAN", "vital_status": "Dead", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "de5a8936-517c-4347-b831-5a662b393670", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "79", "days_to_last_known_alive": null, "days_to_last_followup": "40", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}, {"uuid": "ede02a5d-9d15-42ea-aed0-09673d9846ce", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage II", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "57", "days_to_last_known_alive": null, "days_to_last_followup": "173", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 4, "drug_details": [{"type": "Chemotherapy", "name": "Methotrexate", "start": "16", "end": "51", "duration": 35, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Doxorubicin", "start": "16", "end": "51", "duration": 35, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Vinblastine", "start": "16", "end": "51", "duration": 35, "dosis": null, "dosis_unit": null}, {"type": "Chemotherapy", "name": "Cisplatin", "start": "16", "end": "51", "duration": 35, "dosis": null, "dosis_unit": null}], "qty_radiation": 0, "radiation_details": []}, {"uuid": "3b24f3c5-df6b-4eca-b8f1-f7b8eeff19ef", "tumor_tissue_site": "Bladder", "pathologic_stage": "Stage IV", "histological_type": "Muscle invasive urothelial carcinoma (pT2 or above)", "days_to_death": null, "age_at_initial_pathologic_diagnosis": "72", "days_to_last_known_alive": null, "days_to_last_followup": "195", "days_to_last_follow_up": "", "gender": "MALE", "ethnicity": "NOT HISPANIC OR LATINO", "race": "WHITE", "vital_status": "Alive", "qty_follow_ups": 2, "qty_drugs": 0, "drug_details": [], "qty_radiation": 0, "radiation_details": []}]